Eli Lilly and (LLY) AI Analysis
Score
AI Score 62. The score reflects strong reported profitability, with a net margin of 0.319, offset by elevated valuation multiples of 45.8899 P/E and 31.3949 price-to-book. Growth, estimates, and price-trend evidence were not provided, limiting confidence
Summary
Eli Lilly and Company operates in Healthcare within Drug Manufacturers - General. The company reports a net margin of 31.9% and a dividend yield of 0.5%.
Valuation
The stock trades at a P/E of 45.9 and a price-to-book ratio of 31.4. These multiples indicate a valuation that depends on sustained earnings strength.
Quality
A net margin of 31.9% indicates strong profitability based on the available facts. No balance-sheet, cash-flow, or return-on-capital figures are provided.
Growth
No revenue, earnings-growth, estimate-revision, or price-trend data are provided. Growth cannot be assessed from the supplied facts.
Risks
The P/E of 45.9 and price-to-book ratio of 31.4 create valuation risk if profitability or growth expectations weaken. The dividend yield of 0.5% provides limited income support.